Cytel operates as a data-science CRO serving the full drug development lifecycle—from adaptive trial design through regulatory submission and real-world evidence. The stack is heavily weighted toward statistical programming (SAS, Phoenix WinNonlin, GraphPad Prism, WinBUGS) and clinical data standards (CDISC SDTM, ADaM), with emerging adoption of modern tools like Python and Shiny. The hiring surge is concentrated in data and research roles at senior and principal levels, paired with active projects in SDTM/ADaM dataset generation and statistical analysis—signaling expansion in quantitative capacity to handle larger, more complex pharma engagements.
Cytel is a contract research organization specializing in data science and clinical trial software for pharmaceutical and biotech companies. The company provides end-to-end services across trial design, biometrics, statistical analysis, regulatory submission support, and real-world evidence generation. With over 2,000 employees across North America, Europe, Asia, and multiple hiring markets, Cytel serves large pharma, mid-market biotech, and development-stage sponsors navigating preclinical research through commercialization. Active projects span Phase I–IV trials, adaptive design methodology, dataset standardization (SDTM/ADaM), and protocol development informed by real-world data sources.
Core stack includes SAS, Phoenix WinNonlin, CDISC SDTM/ADaM standards, GraphPad Prism, and WinBUGS for statistical analysis. Modern additions include Python, Shiny, React, PostgreSQL, and Salesforce for analytics and business operations.
Headquartered in Cambridge, MA, Cytel employs 2,000+ staff across North America, Europe, and Asia with active hiring in the United States, India, Ukraine, France, Canada, Romania, South Africa, Poland, Italy, Singapore, Netherlands, and Bulgaria.
Cytel's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.